EndoBridge 2023: highlights and pearls

Bulent Okan Yildiz; Cesar Luiz Boguszewski; Margaret Cristina da Silva Boguszewski; Luca Busetto; Ozlem Celik; Ghada El-Hajj Fuleihan; Dimitrios G Goulis; Gary D Hammer; Megan R Haymart; Gregory Kaltsas; Jennifer R Law; Amanda Yuan Ling Lim; Anton Luger; Djuro Macut; Barbara McGowan; Michael McClung; Alexander Dimitri Miras; Mary Elizabeth Patti; Robin P Peeters; Duarte Pignatelli; Hamayle Saeed; Jennifer Sipos; Constantine A Stratakis; Marina Tsoli; A J van der Lely; Selma F Witchel; Dilek Yazici

doi:10.1007/s42000-024-00549-8

EndoBridge 2023: highlights and pearls

Hormones (Athens). 2024 Apr 15. doi: 10.1007/s42000-024-00549-8. Online ahead of print.

Authors

Bulent Okan Yildiz¹, Cesar Luiz Boguszewski², Margaret Cristina da Silva Boguszewski³, Luca Busetto⁴, Ozlem Celik⁵, Ghada El-Hajj Fuleihan⁶, Dimitrios G Goulis⁷, Gary D Hammer⁸, Megan R Haymart⁸, Gregory Kaltsas⁹, Jennifer R Law¹⁰, Amanda Yuan Ling Lim^{11

12}, Anton Luger¹³, Djuro Macut¹⁴, Barbara McGowan¹⁵, Michael McClung¹⁶, Alexander Dimitri Miras¹⁷, Mary Elizabeth Patti¹⁸, Robin P Peeters¹⁹, Duarte Pignatelli²⁰, Hamayle Saeed¹⁸, Jennifer Sipos²¹, Constantine A Stratakis²², Marina Tsoli²³, A J van der Lely²⁴, Selma F Witchel²⁵, Dilek Yazici²⁶

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, 06100, Hacettepe, Ankara, Turkey. yildizbo@yahoo.com.
² Department of Internal Medicine, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil.
³ Department of Pediatrics, Endocrine Division (SEMPR), University Hospital, Federal University of Parana, Curitiba, Brazil.
⁴ Department of Medicine, University of Padova, Padova, Italy.
⁵ Department of Endocrinology and Metabolism, School of Medicine, Acibadem University, Istanbul, Turkey.
⁶ Division of Endocrinology, Deparment of Medicine at the American University of Beirut, Beirut, Lebanon.
⁷ Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁸ Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.
⁹ First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
¹⁰ Division of Pediatric Endocrinology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
¹¹ Imperial College Healthcare NHS Trust, London, UK.
¹² Division of Endocrinology, Department of Medicine, National University Hospital, Singapore, Singapore.
¹³ Department of Medicine III, Medical University of Vienna, Vienna, Austria.
¹⁴ Institute of Endocrinology, University of Belgrade, Belgrade, Serbia.
¹⁵ Guy's and St Thomas Hospital and King's College London, London, UK.
¹⁶ Oregon Osteoporosis Center, Portland, OR, USA.
¹⁷ School of Medicine, Ulster University, Derry, Londonderry, UK.
¹⁸ Joslin Diabetes Center, Boston, MA, USA.
¹⁹ Department of Internal Medicine, Academic Center for Thyroid Disease, Erasmus University Medical Center, Rotterdam, The Netherlands.
²⁰ Department of Endocrinology, Centro Hospitalar e Universitário de S. João, Porto, Portugal.
²¹ Division Endocrinology, Diabetes and Metabolism, Ohio State University, Columbus, OH, USA.
²² Human Genetics & Precision Medicine, IMBB, FORTH, Heraklion & NICHD, NIH, Bethesda, MD, USA.
²³ Academic Scholar Fellow at 1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, Athens, Greece.
²⁴ Pituitary Center Rotterdam and Division of Endocrinology, Department of Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
²⁵ Division of Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA.
²⁶ Division of Endocrinology, Department of Internal Medicine, School of Medicine, Koç University, Istanbul, Turkey.

PMID: 38619812
DOI: 10.1007/s42000-024-00549-8

Abstract

EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11^th Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders. As usual, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The abstracts of clinical cases presented by the delegates during oral and poster sessions have been published in JCEM Case Reports. Herein, we provide a paper on highlights and pearls of the meeting sessions covering a wide range of subjects, from thyroid nodule stratification to secondary osteoporosis and from glycemic challenges in post-bariatric surgery to male hypogonadism. This report emphasizes the latest developments in the field, along with clinical approaches to common endocrine issues. The 12th annual meeting of EndoBridge will be held on October 17-20, 2024 in Antalya, Turkey.

Keywords: Adrenal; Bone; Diabetes mellitus; Obesity; Pituitary; Thyroid.

Publication types

Review